Cargando…

CRISPR-Cas9 identifies growth-related subtypes of glioblastoma with therapeutical significance through cell line knockdown

BACKGROUND: Glioblastoma (GBM) is a type of highly malignant brain tumor that is known for its significant intratumoral heterogeneity, meaning that there can be a high degree of variability within the tumor tissue. Despite the identification of several subtypes of GBM in recent years, there remains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Nannan, Weng, Siyuan, Liu, Zaoqu, Xu, Hui, Ren, Yuqin, Guo, Chunguang, Liu, Long, Zhang, Zhenyu, Ji, Yuchen, Han, Xinwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424363/ https://www.ncbi.nlm.nih.gov/pubmed/37580710 http://dx.doi.org/10.1186/s12885-023-11131-7

Ejemplares similares

Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2023)

Integrative pharmacogenomics revealed three subtypes with different immune landscapes and specific therapeutic responses in lung adenocarcinoma
por: Ge, Xiaoyong, et al.
Publicado: (2022)

Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma
por: Xing, Zhe, et al.
Publicado: (2022)

CRISPR/Cas13d-Mediated Microbial RNA Knockdown
por: Zhang, Kun, et al.
Publicado: (2020)

Immune perturbation network identifies an EMT subtype with chromosomal instability and tumor immune-desert microenvironment
por: Xu, Hui, et al.
Publicado: (2023)

Enhanced RNA knockdown efficiency with engineered fusion guide RNAs that function with both CRISPR-CasRx and hammerhead ribozyme
por: Zhan, Yonghao, et al.
Publicado: (2023)

Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice
por: Yu, Wenhan, et al.
Publicado: (2017)

HIV-1 mRNA Knockdown with CRISPR/Cas9 Enhances Neurocognitive Function
por: McLaurin, Kristen A, et al.
Publicado: (2023)

Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme
por: Al-Sammarraie, Nadia, et al.
Publicado: (2021)

Engineered Extracellular Vesicle-Delivered CRISPR/Cas9 for Radiotherapy Sensitization of Glioblastoma
por: Liu, Xiao, et al.
Publicado: (2023)

Gene interaction perturbation network deciphers a high-resolution taxonomy in colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2022)

CD8+ T cell trajectory subtypes decode tumor heterogeneity and provide treatment recommendations for hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2022)

Divergent methylation of CRISPR repeats and cas genes in a subtype I-D CRISPR-Cas-system
por: Scholz, Ingeborg, et al.
Publicado: (2019)

Structural and functional characterization of Cas2 of CRISPR-Cas subtype I-C lacking the CRISPR component
por: Anand, Vineet, et al.
Publicado: (2022)

TTN/OBSCN ‘Double‐Hit’ predicts favourable prognosis, ‘immune‐hot’ subtype and potentially better immunotherapeutic efficacy in colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Targeted RNA Knockdown by a Type III CRISPR-Cas Complex in Zebrafish
por: Fricke, Thomas, et al.
Publicado: (2020)

Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment
por: Xu, Hui, et al.
Publicado: (2022)

Targeting cellular mRNAs translation by CRISPR-Cas9
por: Liu, Yuchen, et al.
Publicado: (2016)

Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options
por: Liu, Zaoqu, et al.
Publicado: (2022)

Implications of pseudogenes for the prognosis of hepatocellular carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2023)

Mutagenesis and homologous recombination in Drosophila cell lines using CRISPR/Cas9
por: Bassett, Andrew R., et al.
Publicado: (2013)

CRISPR/Cas9-mediated genome editing induces gene knockdown by altering the pre-mRNA splicing in mice
por: Tang, Ji-Xin, et al.
Publicado: (2018)

Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

A Guild of 45 CRISPR-Associated (Cas) Protein Families and Multiple CRISPR/Cas Subtypes Exist in Prokaryotic Genomes
por: Haft, Daniel H, et al.
Publicado: (2005)

FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity
por: Cui, Zifeng, et al.
Publicado: (2022)

OMRT-12. Nanoparticle-based CRISPR-Cas9 delivery for anti-glioblastoma immunotherapy
por: Aguilar, Rocio, et al.
Publicado: (2021)

CRISPR-Cas9 Knockdown and Induced Expression of CD133 Reveal Essential Roles in Melanoma Invasion and Metastasis
por: Simbulan-Rosenthal, Cynthia M., et al.
Publicado: (2019)

CRISPR-cas Subtype I-Fb in Acinetobacter baumannii: Evolution and Utilization for Strain Subtyping
por: Karah, Nabil, et al.
Publicado: (2015)

Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2022)

Improving transgene expression and CRISPR‐Cas9 efficiency with molecular engineering‐based molecules
por: Zhan, Hengji, et al.
Publicado: (2020)

Protocol for biallelic tagging of an endogenous gene using CRISPR-Cas9 in human cells
por: Kong, Nannan, et al.
Publicado: (2023)

Epigenetically regulated gene expression profiles decipher four molecular subtypes with prognostic and therapeutic implications in gastric cancer
por: Weng, Siyuan, et al.
Publicado: (2023)

CRISPR/Cas9, a new approach to successful knockdown of ABCB1/P-glycoprotein and reversal of chemosensitivity in human epithelial ovarian cancer cell line
por: Norouzi-Barough, Leyla, et al.
Publicado: (2018)

Genome-wide CRISPR/Cas9 screening identifies CARHSP1 responsible for radiation resistance in glioblastoma
por: Zhu, Guo-dong, et al.
Publicado: (2021)

Valproic Acid Significantly Improves CRISPR/Cas9-Mediated Gene Editing
por: Park, Hanseul, et al.
Publicado: (2020)

Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Editorial: The role of multi-omics variants in tumor immunity and immunotherapy
por: Chen, Shuang, et al.
Publicado: (2022)

CRISPR-Cas9/Cas12a biotechnology and application in bacteria
por: Yao, Ruilian, et al.
Publicado: (2018)

A New Trend in Cancer Treatment: The Combination of Epigenetics and Immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2022)

Gene Expression Profile Reveals a Prognostic Signature of Non–MSI-H/pMMR Colorectal Cancer
por: Liu, Zaoqu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ksll6erbe2fo7knddjng8kpdja